Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 483-487 , December 2009

Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary

  • A. Ligey

      Affiliations

    • Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon Cedex, France
    • Corresponding Author InformationCorresponding author.
    • ,
  • J. Gentil

      Affiliations

    • Department of Medical Information, Centre Georges-François Leclerc, Dijon, France
    • ,
  • G. Créhange

      Affiliations

    • Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon Cedex, France
    • ,
  • X. Montbarbon

      Affiliations

    • Department of Radiation Oncology, Centre Léon Bérard, Lyon, France
    • ,
  • P. Pommier

      Affiliations

    • Department of Radiation Oncology, Centre Léon Bérard, Lyon, France
    • ,
  • K. Peignaux

      Affiliations

    • Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon Cedex, France
    • ,
  • G. Truc

      Affiliations

    • Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon Cedex, France
    • ,
  • P. Maingon

      Affiliations

    • Department of Radiation Oncology, Centre Georges-François Leclerc, Dijon Cedex, France

Received 31 December 2008 ,Revised 29 July 2009 ,Accepted 11 August 2009.

References 

  1. Friesland S, Lind MG, Lundgren J, Munck-Wikland E, Fernberg JO. Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin. Acta Oncol. 2001;40:24–28
  2. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol. 2000;55:121–129
  3. Jungehulsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, et al. 2[F]-fluoro-2-deoxy-d-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg. 2000;123:294–301
  4. Randall DA, Johnstone PA, Foss RD, Martin PJ. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg. 2000;122:52–55
  5. Aslani M, Sultanem K, Voung T, Hier M, Niazi T, Shenouda G. Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: is there a need for neck dissection?. Head Neck. 2007;29:585–590
  6. Beldi D, Jereczek-Fossa BA, D’Onofrio A, Gambaro G, Fiore MR, Pia F, et al. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys. 2007;69:1051–1058
  7. Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck. 1998;20:674–681
  8. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys. 2001;50:55–63
  9. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys. 1997;37:797–802
  10. Strojan P, Anicin A. Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol. 1998;49:33–40
  11. de Braud F, al-Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol. 1993;20:273–278
  12. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004;30:153–164
  13. Kirschner MJ, Fietkau R, Waldfahrer F, Iro H, Sauer R. Therapy pf cervical lymph node metastases of unknown primary tumor. Strahlenther Onkol. 1997;173:362–368
  14. Gregoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006;79:15–20
  15. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227–236
  16. Coster JR, Foote RL, Olsen KD, Jack SM, Schaid DJ, DeSanto LW. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys. 1992;23:743–749
  17. Harper CS, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy. Head Neck. 1990;12:463–469
  18. Fernandez JA, Suarez C, Martinez JA, Llorente JL, Rodrigo JP, Alvarez JC. Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors. Clin Otolaryngol Allied Sci. 1998;23:158–163
  19. Sinnathamby K, Peters LJ, Laidlaw C, Hughes PG. The occult head and neck primary: to treat or not to treat?. Clin Oncol (R Coll Radiol). 1997;9:322–329
  20. Weir L, Keane T, Cummings B, Goodman P, O’Sullivan B, Payne D, et al. Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol. 1995;35:206–211
  21. Bataini JP, Rodriguez J, Jaulerry C, Brugere J, Ghossein NA. Treatment of metastatic neck nodes secondary to an occult epidermoid carcinoma of the head and neck. Laryngoscope. 1987;97:1080–1084
  22. Glynne-Jones RG, Anand AK, Young TE, Berry RJ. Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:289–294
  23. Marcial-Vega VA, Cardenes H, Perez CA, Devineni VR, Simpson JR, Fredrickson JM, et al. Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys. 1990;19:919–928
  24. Maulard C, Housset M, Brunel P, Rozec C, Ucla L, Delanian S, et al. Primary cervical lymph nodes of epidermoid type. Results of a series of 123 patients treated by the association surgery-radiotherapy or irradiation alone. Ann Otolaryngol Chir Cervicofac. 1992;109:6–13
  25. Nieder C, Gregoire V, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?. Int J Radiat Oncol Biol Phys. 2001;50:727–733
  26. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP. Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg. 1994;168:395–399
  27. Lefebvre JL, Coche-Dequeant B, Van JT, Buisset E, Adenis A. Cervical lymph nodes from an unknown primary tumor in 190 patients. Am J Surg. 1990;160:443–446
  28. Nguyen C, Shenouda G, Black MJ, Vuong T, Donath D, Yassa M. Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites. Head Neck. 1994;16:58–63
  29. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys. 2008;71:1158–1166
  30. Medini E, Medini AM, Lee CK, Gapany M, Levitt SH. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol. 1998;21:121–125

PII: S0167-8140(09)00441-1

doi: 10.1016/j.radonc.2009.08.027

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 483-487 , December 2009

Article Tools

* Image Usage & Resolution